Official State of Rhode Island website

  • Change the visual color theme between light or dark modes
  • Adjust the font size from the system default to a larger size
  • Adjust the space between lines of text from the system default to a larger size
  • Adjust the space between words from the system default to a larger size

Candida species

Clinical Specimen Submission Guidance

Submit all specimens to 50 Orms St, Providence RI 02904. Open Monday to Friday 8:30 AM to 4:30 PM

Lab

Special Pathogens & Biothreats Laboratory 401-222-5586

Analyte Name

Candida auris, Candida species (other than Candida albicans)

Disease

Candida auris

Test Description

Collect and confirm Candida species isolates (other than C. albicans).

The Matrix-Assisted Laser Desorption/Ionization Time -of -Flight Mass Spectrometry (MALDI-TOF MS) Biotyper CA (Bruker Daltonics Inc.) and its reference library of species are cleared by the U.S. Food and Drug Administration (FDA) for the identification of microorganisms. The performance characteristics of the MALDI-TOF system were verified by the Rhode Island State Health Laboratories. Additional species not contained in the FDA-approved reference library were extensively validated prior to reporting.

Per request of the CDC, isolates are being collected for potential shipment to the Regional Reference Laboratory for further characterization.

Special Instructions

Isolates to submit to RISHL:

All confirmed or suspected Candida auris isolates from any specimen source

Antifungal resistant candida species, other than C. albicans, from any specimen source, especially invasive sites

Yeast isolates from any specimen source after attempt to identify was unsuccessful

Additional Information:

Candida species and CRE/CRPA testing letter sent to RI Sentinel Microbiology Laboratories https://health.ri.gov/publications/specimenguidances/Candida-2022-Letter-To-Sentinel-Labs.pdf

Update to the Standardized Case Definition and Notification for Candida auris https://health.ri.gov/publications/specimenguidances/Candida-CSTE-22-ID-05_C_auris.pdf

Specimen

Preferred: an 18-24 hour pure isolate on a Sabouraud Dextrose agar plate or a blood agar plate sealed with parafilm or other appropriate barrier film.

If transport is delayed, minimize excessive subculturing and keep plate refrigerated at 2-8°C to preserve resistance mechanism.

 

Specimen Identification

CLIA regulations require specimens be labeled with at least two patient identifiers. Examples of identifiers are first and last name, date of birth, chart/medical record number. The specimen container must be labeled to match the test requisition or the electronic order.

Form Required

Rhode Island State Health Laboratories (RISHL) test requisition form https://health.ri.gov/forms/LabRequisitionForm.pdf

Copies of all susceptibility and mechanistic testing reports.

Test Request

Bacterial Isolate (ID/Confirmation)

Write Candida under Comments/Other test requests.

Indicate whether the isolate is derived from a clinical or screening/surveillance culture.

Transport

As soon as possible at ambient temperature, in a yellow-top transport container.

Specimens must be packaged & transported in accordance with current federal shipping regulations.

 

Reporting Requirement

Providers must report patient information on Candida auris immediately using the RIDOH reportable disease form.

Turnaround Time

 2 business days

Kit

Containers specifically labeled for transport of specimens and isolates to the RISHL Special Pathogens and Biotreats Laboratory are available in all Microbiology Laboratories and Laboratory Sendout Departments.